Evaluation of the stopping angiotensin converting enzyme inhibitor compared to angiotensin receptor blocker (STOP ACEi trial) in advanced and progressive chronic kidney disease
Sunil Bhandari, Samir Mehta, A. R. Khawaja, John G.F. Cleland, Natalie Ives, Paul Cockwell
Topics & Concepts
MedicineHazard ratioKidney diseaseDiscontinuationRenal functionInternal medicineAngiotensin-converting enzymeConfidence intervalACE inhibitorRandomized controlled trialRelative riskUrologyKidneyAngiotensin receptorRenin–angiotensin systemGastroenterologyEndocrinologyBlood pressureRenin-Angiotensin System StudiesBlood Pressure and Hypertension StudiesHormonal Regulation and Hypertension